Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications characteristics influencing japanese atrial fibrillation patients preferences
… in applying stated-preference methods to elicit the preferences of patients and other healthcare decision-makers. Her most … and Value research theme. She has over 50 peer-reviewed publications in journals that include Journal of Health …
… stated preference methods to measuring the benefit-risk preferences of patients and other health care decision-makers. She has been … the ISPOR FDA summit. She has over 50 peer-reviewed publications in journals that include The Patient, Value in …
… measured by the PRO instrument should be meaningful to patients. Consideration should also be given to aspects of a given concept that may be important to patients (e.g., frequency, severity, interference with … activities of daily living). The agency recognizes that patients may prioritize some concepts over others (for …
… proposition in simple language that can be understood by patients or other stakeholders as well. There is no point of …
Jayne Galinsky Health Preference Assessment Telecommuter - UK DPhil, Health Science University of Stirling, Stirling, Scotland BA, Social Science Glasgow Caledonian University, Glasgow, United Kingdom Jayne Galinsky, PhD, is a Research Economist in the …
… More than ever, health economic information affects how patients, providers, payers , and regulators make decisions, …
… for the case-finding study. RTI-HS interviewed patients about any prior use of FORTEO®, other medications … risk factors. In the other studies, Information on FORTEO® patients (and in two studies, comparator patients) was linked to cancer registry data to identify new …
… likelihood of brain metastases. Overall survival rates for patients with NSCLC with brain metastases are low. New … scientists assessing real-world clinical outcomes in patients with NSCLC with a rare MET exon 14 skipping mutation … has been published. Research Focus The study focused on patients who had received treatment with the MET inhibitor …
… as “at risk” to describe communities, individuals, and patients. Instead, “at risk” should be used to describe … or situations that people experience (for example, patients at risk of developing diabetes; Black patients at risk of developing sickle cell anemia). Along …
RTI-HS Webinar - Lessons Learned From a Review of FDA PRO Labeling Share on: December 12, 2016 Image Click to view this webinar - Lessons Learned from a Review of FDA PRO Labeling The last decade has seen an increased focus on patient-centered drug …